AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool

AI-powered digital pathology (AI-DP) as a pathologist's assistance tool can be utilized to improve pathologist concordance. However, pathologist judgement remains critical. In this study, we evaluated how pathologists used the assistance tool and how the platform impacted their decision-making. The findings are significant for pathologists and clinical researchers as they provide guidance for the well-informed use of SHG-based AI-DP as a tool to aid pathologists in fibrosis scoring in metabolic dysfunction-associated steatohepatitis. The insights gained can further inform policymakers about the integration of AI technologies in clinical trials or pathology workflows in clinical practice, promoting standardized practices.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2026-01-29
DOI
https://doi.org/10.1016/j.jhepr.2026.101752
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool

Gwyneth Shook Ting Soon, Saswata Talukdar, Arun Jayant Sanyal, Serene Lek et al.
JHEP Reports
AI in cancer detection
article

AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool

Gwyneth Shook Ting Soon, Saswata Talukdar, Arun Jayant Sanyal, Serene Lek, Michael O. Idowu, Asad Ali, Desiree Abdurrachim, Samuel S. Engel, Gideon Ho, Aileen Wee, Timothy J. Kendall, Chih-Liang Chin
article en

Abstract

AI-powered digital pathology (AI-DP) as a pathologist's assistance tool can be utilized to improve pathologist concordance. However, pathologist judgement remains critical. In this study, we evaluated how pathologists used the assistance tool and how the platform impacted their decision-making. The findings are significant for pathologists and clinical researchers as they provide guidance for the well-informed use of SHG-based AI-DP as a tool to aid pathologists in fibrosis scoring in metabolic dysfunction-associated steatohepatitis. The insights gained can further inform policymakers about the integration of AI technologies in clinical trials or pathology workflows in clinical practice, promoting standardized practices.

JHEP ReportsVol. 8(4)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Virginia Commonwealth University (US), Quantitative BioSciences (US), National Cancer Institute (US), National University Hospital (SG), Centre for Inflammation Research (GB), Histoindex (Singapore) (SG)
Peace, Justice and strong institutions
Openalex Percentile: Top 75%
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.